Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival.
about
Role of liver transplantation for hepatocellular carcinomaLiver resection and transplantation in hepatocellular carcinomaResection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria?Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Liver transplantation versus surgical resection for HCC meeting the Milan criteria: A propensity score analysis.Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide.Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition.Role of hepatectomy for recurrent or initially unresectable hepatocellular carcinoma.Combination of intratumoral invariant natural killer T cells and interferon-gamma is associated with prognosis of hepatocellular carcinoma after curative resection.Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma.Early Hepatocellular Carcinoma: Transplantation versus Resection: The Case for Liver Resection.Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States.Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study.Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?NCCN clinical practice guidelines in oncology: hepatobiliary cancersPhosphorylated Heat Shock Protein 20 (HSPB6) Regulates Transforming Growth Factor-α-Induced Migration and Invasion of Hepatocellular Carcinoma Cells.Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma.A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expressionA prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection.Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single Center Experience.LIN28 expression and prognostic value in hepatocellular carcinoma patients who meet the Milan criteria and undergo hepatectomy.Orthotopic liver transplantation as a rescue operation for recurrent hepatocellular carcinoma after partial hepatectomy.Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8,900 high-risk patients.Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20-year experience.HCC: current surgical treatment concepts.Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma.Is resection equivalent to transplantation for early cirrhotic patients with hepatocellular carcinoma? A meta-analysis.Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis.Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria.Treatment of hepatocellular carcinoma: a systematic review.Hepatocellular carcinoma: a comprehensive overview of surgical therapy.Super-selection of a subgroup of hepatocellular carcinoma patients at minimal risk of recurrence for liver transplantation.Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration.Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection.Salvage liver transplantation after laparoscopic resection for hepatocellular carcinoma: a multicenter experience.p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways.
P2860
Q26822581-D4D2A0EE-8649-41A5-8EE0-F4B4EF399638Q26823395-61BA962D-E38D-4279-AF38-F54D2F25C703Q30410247-567CE6F4-48BE-42FB-A780-EB416EF08071Q30479629-443EBDB9-6A51-4E5E-8C97-AAA5399FD99FQ33437967-DD147394-8C08-4701-8168-F14BEB1C88E1Q33960740-38C7C517-9CA4-42C0-ADA2-2B2B99760620Q34400157-F2AB6816-CE89-4E86-BFFE-2F653CA908E5Q34405052-231562BC-A803-445D-BD3C-DC7381F660FAQ34728246-13B334DA-DFED-407A-87FB-24CA5DACA477Q34934974-0DF907A8-AE25-4F33-86FF-EFEE17608808Q35007692-1F228061-5AB8-4D9A-807C-24CF6AD304F6Q35207490-2EB57711-E2AA-44B4-A3FB-0A838C6B9C28Q35322713-7523BBE5-5EAE-4CEF-AF36-95DE127E4C3CQ35384660-016BB3EF-36AE-4266-9802-54CDD9DDDE66Q35422169-8252B4C6-3611-4155-AC15-E17E5DDCF33CQ35586420-7B8729ED-1115-4B48-B244-9F2F5610759EQ35703937-8659F9C6-2729-4715-8D65-EC4BDE2610E7Q35979922-DCE3C2B7-1610-4A24-B617-4BBC5E82D55AQ36082204-641F1D24-7787-463D-A203-37A51673D6A5Q36251372-06BBEB78-A549-493C-90F0-9728B3D84E27Q36335396-6DF93947-3C30-4223-A31A-CE9F2CAF95E0Q36962089-BC1C53D2-FAB9-4148-BED2-E4279EB08806Q37012028-D338C363-2552-4626-9137-27FFCBBE51F1Q37183805-A29C2EBB-7AA5-4F0E-8149-DA9785BE11B6Q37316681-C88B8A91-F055-4313-9345-22D4FFF2F6B4Q37350320-0D099D74-C8C6-4E08-A97C-15503F1E3060Q37376461-049228D7-4988-42A6-A412-4956A4895372Q37628461-D886C5F0-42CD-4F9B-BDE9-6909B3F5B2CFQ37980015-634257A7-E6D4-43EA-A522-496517E653A8Q37995306-47C775E4-B9B0-48BF-8D00-527E70E22CEEQ38029966-BB426618-4D6B-4D9C-A5CE-14FE0EE20933Q38033646-ABD68115-8888-48D0-ADC6-394735B7EE7BQ38048224-12DCD5B0-4E30-488F-9B5E-6BC974029A65Q38155508-B9F9B466-BDB4-496A-B0FE-61497031DCACQ38217436-9D3B4458-6877-4123-B540-BB7C878219A5Q38474433-AFC8F20F-2C7F-49F3-ABAF-32EB2C97AD65Q38769255-36607BF1-325B-4941-9A7B-28F42FC22A88Q38966147-044C9E19-B584-4C09-8539-E24F9AAE24DBQ38981511-64DC29DB-A544-41A6-B547-B15916F2815DQ39604806-A5428529-7FA9-490E-BCA4-776D6CA92808
P2860
Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Difference in tumor invasivene ...... impact on long-term survival.
@en
Difference in tumor invasivene ...... impact on long-term survival.
@nl
type
label
Difference in tumor invasivene ...... impact on long-term survival.
@en
Difference in tumor invasivene ...... impact on long-term survival.
@nl
prefLabel
Difference in tumor invasivene ...... impact on long-term survival.
@en
Difference in tumor invasivene ...... impact on long-term survival.
@nl
P2093
P2860
P1433
P1476
Difference in tumor invasivene ...... impact on long-term survival.
@en
P2093
Chi Leung Liu
Chung Mau Lo
Ronnie T P Poon
Sheung Tat Fan
P2860
P356
10.1097/01.SLA.0000225255.01668.65
P407
P577
2007-01-01T00:00:00Z